Table 1 The clinicopathologic characters of 1033 Chinese lung cancer patients.
From: Elderly male smokers with right lung tumors are viable candidates for KRAS mutation screening
Number | Percentage | Number | Percentage | |
|---|---|---|---|---|
Gender | ||||
Male | 597 | 57.79% | ||
Female | 436 | 42.21% | ||
Age | Female | Male | ||
<30 | 3 | 0.69% | 1 | 0.17% |
31–40 | 13 | 2.98% | 9 | 1.51% |
41–50 | 67 | 15.37% | 59 | 9.88% |
51–60 | 145 | 33.26% | 183 | 30.65% |
61–70 | 157 | 36.01% | 242 | 40.54% |
>70 | 51 | 11.70% | 103 | 17.25% |
Site | ||||
Left | 171 | 39.22% | 243 | 40.70% |
Right | 252 | 57.80% | 340 | 56.95% |
Bilateral | 13 | 2.98% | 14 | 2.35% |
TNM stage | ||||
Stage I | 313 | 71.79% | 359 | 60.13% |
Stage II | 33 | 7.57% | 81 | 13.57% |
Stage III | 65 | 14.91% | 133 | 22.29% |
Stage IV | 25 | 5.73% | 24 | 4.02% |
Smoking | ||||
Never smoker | 403 | 92.43% | 221 | 37.02% |
<100 | 2 | 0.46% | 2 | 0.34% |
101–500 | 23 | 5.28% | 139 | 23.28% |
501–1000 | 7 | 1.61% | 189 | 31.66% |
>1000 | 1 | 0.23% | 46 | 7.71% |
Tumor size (mm) | ||||
1–10 | 78 | 17.89% | 79 | 13.23% |
11–20 | 138 | 31.65% | 155 | 25.96% |
21–30 | 122 | 27.98% | 160 | 26.80% |
31–40 | 60 | 13.76% | 88 | 14.74% |
41–50 | 13 | 2.98% | 51 | 8.54% |
51–60 | 18 | 4.13% | 33 | 5.53% |
61–70 | 2 | 0.46% | 14 | 2.35% |
71–80 | 1 | 0.23% | 8 | 1.34% |
81–90 | 1 | 0.23% | 3 | 0.50% |
91–100 | 2 | 0.46% | 4 | 0.67% |
>100 | 1 | 0.23% | 2 | 0.34% |
Visceral pleura invasion | ||||
Yes | 170 | 38.99% | 165 | 27.64% |
No | 266 | 61.01% | 432 | 72.36% |
